SIG
52
3
FITB
63
3
GE
67
2
FTI
81
5
HP
48
3
INTU
56
-4
BSX
67
-3
CA
38
6
BWA
48
2
HCP
66
8
SWK
64
5
SCHW
62
-2
SEE
56
6
HON
67
2
WBA
48
4
VFC
53
5
CL
58
2
AVY
53
3
NSC
60
3
CRM
67
2
SIG
52
3
FITB
63
3
GE
67
2
FTI
81
5
HP
48
3
INTU
56
-4
BSX
67
-3
CA
38
6
BWA
48
2
HCP
66
8
SWK
64
5
SCHW
62
-2
SEE
56
6
HON
67
2
WBA
48
4
VFC
53
5
CL
58
2
AVY
53
3
NSC
60
3
CRM
67
2
Financhill
Back

Adaptimmune Therapeutics PLC Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
53.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Adaptimmune Therapeutics PLC Stock Forecast

  • Is Adaptimmune Therapeutics PLC Stock Undervalued?
    The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Adaptimmune Therapeutics PLC Stock Go Up Next Year?

Data Unavailable

Adaptimmune Therapeutics PLC Stock Rating

Data Unavailable

Adaptimmune Therapeutics PLC Stock Price History

Is ADAP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adaptimmune.com

52-Week Data

52-Week High:
2.05
52-Week Low:
0.42

Prediction Charts

Market Cap:
169.29M
Price in USD:
0.66
Volume:
1.34M
Beta:
2.15

Technical Analysis

SMA50:
0.84
SMA100:
1.00
SMA200:
1.11
52-Wk Change:
47.35%

Stock Predictions

  • Is Adaptimmune Therapeutics PLC stock public?
    Yes, Adaptimmune Therapeutics PLC is a publicly traded company.
  • What is the Adaptimmune Therapeutics PLC stock quote today?
    The Adaptimmune Therapeutics PLC stock price is 0.66 USD today.
  • How to buy Adaptimmune Therapeutics PLC stock online?
    You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 0.82 0.83 0.83 0.79
Nov-6 0.82 0.83 0.86 0.79
Nov-7 0.82 0.78 0.83 0.77
Nov-8 0.78 0.80 0.80 0.75
Nov-11 0.81 0.82 0.83 0.78
Nov-12 0.82 0.79 0.82 0.76
Nov-13 0.82 0.77 0.83 0.75
Nov-14 0.81 0.59 0.81 0.58
Nov-15 0.59 0.59 0.61 0.58
Nov-18 0.60 0.60 0.64 0.58
Nov-19 0.60 0.67 0.68 0.57
Nov-20 0.68 0.66 0.71 0.64
Nov-21 0.66 0.64 0.68 0.63
Nov-22 0.63 0.66 0.66 0.60

Adaptimmune Therapeutics PLC Earnings

Data Unavailable

Adaptimmune Therapeutics PLC Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.